Andrew Chou, MD, FRCS

Pediatric orthopaedic surgeon, health technology innovator, startup advisor, and surgical educator

Singapore

About

Triple fellowship trained, Stanford and Duke educated paediatric orthopaedic surgeon working at the intersection of medicine, technology, and biodesign. Global network spanning from Silicon Valley to Asia-Pacific. Clinical expertise in hip preservation, sports medicine, and pediatric trauma. Studied bioengineering at Stanford, medicine at the Duke/National University of Singapore Medical School, and orthopaedic surgery at the Royal College of Surgeons of Edinburgh. Over a decade of experience in basic, translational, and clinical research in orthopaedics, surgical education, and healthcare innovation. Chosen as one of four nationally selected global innovation fellows to train in health technology innovation at Stanford Biodesign. Collaborates with medtech venture capital firms and startups in Asia focusing on clinical product fit, clinical trial design, regulatory and intellectual property strategy, business plan development, and commercialization.

Experience

  • KK Women's and Children's Hospital (Full-time · 3 yrs)
    • Consultant Paediatric Orthopaedic Surgeon
      Nov 2025 - Present · 9 mos

    • Associate Consultant Paediatric Orthopaedic Surgeon
      Aug 2023 - Nov 2025 · 2 yrs 4 mos

      • Paediatric orthopaedic surgeon with expertise in paediatric trauma, hip preservation, lower limb reconstruction, and sports medicine. • Principal investigator for orthopaedic trials and initiatives including AEON (Artificial-Intelligence Enhanced Orthopaedic Navigation), Castomize 4D printed casts, Bot MD AI-powered clinical registry, and Bot MD gen AI chatbot for parents. • Paediatric Orthopaedics / Sports, Arthroscopy, and Joint Preservation fellowship faculty and supervisor. • Clinical Lead for 3D printing for the KKH Division of Surgery and the Orthopaedic Residency Intelligent Fabrication (O.R.I.F.) initiative. • Designated Innovation Champion and Patient Safety Officer. • Paediatric Point-of-Care Ultrasound (POCUS) Workgroup. • SingHealth Artificial Intelligence in Medicine Institute Faculty Member. • SingHealth Innovation Committee Member. • SingHealth Academic Medicine-NHIC Joint Medtech Grant Clinical Evaluator. • Agency for Care Effectiveness (ACE) Innovations Trends Workgroup identifying upcoming disruptive tech in healthcare. • KK Women’s and Children’s Hospital (KKH) is Singapore’s largest tertiary referral centre for obstetrics, gynaecology, paediatrics and neonatology. The academic medical centre specialises in the management of high-risk conditions in women and children. Driven by a commitment to deliver compassionate, multidisciplinary care to patients, KKH leverages innovation to advance care.

  • Clinical Assistant Professor & Course Director for Duke Innovate at Duke-NUS Medical School
    Oct 2018 - Present · 7 yrs 10 mos

    • Teach, supervise, and mentor medical students rotating through the Department of Orthopaedic Surgery at KKH on the fundamentals of fractures in children, common physiological conditions, and managing musculoskeletal pathology. • Designed curriculum and taught a first-of-its-kind innovation course for future physicians on utilizing design thinking and implementing innovation in healthcare, drawing from case studies in academic research, medical devices, digital health, and global health. • Feedback and research data from the course won awards at the SingHealth Duke-NUS Education Congress 2019 and was published subsequently in The Clinical Teacher.

  • Venture Partner & Startup Mentor at BE Accelerator (比翼加速器)
    Feb 2020 - Present · 6 yrs 6 mos

    • BE Healthcare Ventures is a multi-stage healthcare investment fund based in Taiwan with a focus on three core healthcare area: Digital Health, AI in Medicine and Medical Devices.

  • Clinical Advisor at VentureBlick
    Feb 2023 - Present · 3 yrs 6 mos

    • Redefining Medtech Venture Building.

  • Mentor in Residence at MedTech Actuator
    Mar 2024 - Present · 2 yrs 5 mos

    • Aggressively accelerating and funding MedTech, HealthTech and BioTech ventures across Asia Pacific.